The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Safety and Pharmacovigilance Software Market Research Report 2024
Synopsis
Drug Safety and Pharmacovigilance Software is scientific research software that discovers, evaluates, understands and prevents adverse reactions or any other problems that may be related to drugs.
The global Drug Safety and Pharmacovigilance Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Safety and Pharmacovigilance Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Safety and Pharmacovigilance Software.
Report Scope
The Drug Safety and Pharmacovigilance Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Safety and Pharmacovigilance Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Safety and Pharmacovigilance Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB cube
Max Application
Ennov Solutions Inc
ArisGlobal
EXTEDO GmbH
Online Business Applications Inc
Oracle Corporation
Sparta Systems, Inc.
United BioSource Corporation
Sarjen Systems
Segment by Type
ADR Reporting
Drug Safety Audits
Issue Tracking
Fully Integrated Software
Segment by Application
Pharma & Biotech Companies
CROs
BPOs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Safety and Pharmacovigilance Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug Safety and Pharmacovigilance Software is scientific research software that discovers, evaluates, understands and prevents adverse reactions or any other problems that may be related to drugs.
The global Drug Safety and Pharmacovigilance Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Safety and Pharmacovigilance Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Safety and Pharmacovigilance Software.
Report Scope
The Drug Safety and Pharmacovigilance Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Safety and Pharmacovigilance Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Safety and Pharmacovigilance Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB cube
Max Application
Ennov Solutions Inc
ArisGlobal
EXTEDO GmbH
Online Business Applications Inc
Oracle Corporation
Sparta Systems, Inc.
United BioSource Corporation
Sarjen Systems
Segment by Type
ADR Reporting
Drug Safety Audits
Issue Tracking
Fully Integrated Software
Segment by Application
Pharma & Biotech Companies
CROs
BPOs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Safety and Pharmacovigilance Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Safety and Pharmacovigilance Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ADR Reporting
1.2.3 Drug Safety Audits
1.2.4 Issue Tracking
1.2.5 Fully Integrated Software
1.3 Market by Application
1.3.1 Global Drug Safety and Pharmacovigilance Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharma & Biotech Companies
1.3.3 CROs
1.3.4 BPOs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Safety and Pharmacovigilance Software Market Perspective (2019-2030)
2.2 Drug Safety and Pharmacovigilance Software Growth Trends by Region
2.2.1 Global Drug Safety and Pharmacovigilance Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Safety and Pharmacovigilance Software Historic Market Size by Region (2019-2024)
2.2.3 Drug Safety and Pharmacovigilance Software Forecasted Market Size by Region (2025-2030)
2.3 Drug Safety and Pharmacovigilance Software Market Dynamics
2.3.1 Drug Safety and Pharmacovigilance Software Industry Trends
2.3.2 Drug Safety and Pharmacovigilance Software Market Drivers
2.3.3 Drug Safety and Pharmacovigilance Software Market Challenges
2.3.4 Drug Safety and Pharmacovigilance Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Safety and Pharmacovigilance Software Players by Revenue
3.1.1 Global Top Drug Safety and Pharmacovigilance Software Players by Revenue (2019-2024)
3.1.2 Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Players (2019-2024)
3.2 Global Drug Safety and Pharmacovigilance Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Safety and Pharmacovigilance Software Revenue
3.4 Global Drug Safety and Pharmacovigilance Software Market Concentration Ratio
3.4.1 Global Drug Safety and Pharmacovigilance Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Safety and Pharmacovigilance Software Revenue in 2023
3.5 Drug Safety and Pharmacovigilance Software Key Players Head office and Area Served
3.6 Key Players Drug Safety and Pharmacovigilance Software Product Solution and Service
3.7 Date of Enter into Drug Safety and Pharmacovigilance Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Safety and Pharmacovigilance Software Breakdown Data by Type
4.1 Global Drug Safety and Pharmacovigilance Software Historic Market Size by Type (2019-2024)
4.2 Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Type (2025-2030)
5 Drug Safety and Pharmacovigilance Software Breakdown Data by Application
5.1 Global Drug Safety and Pharmacovigilance Software Historic Market Size by Application (2019-2024)
5.2 Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Safety and Pharmacovigilance Software Market Size (2019-2030)
6.2 North America Drug Safety and Pharmacovigilance Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Safety and Pharmacovigilance Software Market Size by Country (2019-2024)
6.4 North America Drug Safety and Pharmacovigilance Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Safety and Pharmacovigilance Software Market Size (2019-2030)
7.2 Europe Drug Safety and Pharmacovigilance Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Safety and Pharmacovigilance Software Market Size by Country (2019-2024)
7.4 Europe Drug Safety and Pharmacovigilance Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size (2019-2030)
8.2 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Safety and Pharmacovigilance Software Market Size (2019-2030)
9.2 Latin America Drug Safety and Pharmacovigilance Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Safety and Pharmacovigilance Software Market Size by Country (2019-2024)
9.4 Latin America Drug Safety and Pharmacovigilance Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size (2019-2030)
10.2 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB cube
11.1.1 AB cube Company Detail
11.1.2 AB cube Business Overview
11.1.3 AB cube Drug Safety and Pharmacovigilance Software Introduction
11.1.4 AB cube Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.1.5 AB cube Recent Development
11.2 Max Application
11.2.1 Max Application Company Detail
11.2.2 Max Application Business Overview
11.2.3 Max Application Drug Safety and Pharmacovigilance Software Introduction
11.2.4 Max Application Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.2.5 Max Application Recent Development
11.3 Ennov Solutions Inc
11.3.1 Ennov Solutions Inc Company Detail
11.3.2 Ennov Solutions Inc Business Overview
11.3.3 Ennov Solutions Inc Drug Safety and Pharmacovigilance Software Introduction
11.3.4 Ennov Solutions Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.3.5 Ennov Solutions Inc Recent Development
11.4 ArisGlobal
11.4.1 ArisGlobal Company Detail
11.4.2 ArisGlobal Business Overview
11.4.3 ArisGlobal Drug Safety and Pharmacovigilance Software Introduction
11.4.4 ArisGlobal Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.4.5 ArisGlobal Recent Development
11.5 EXTEDO GmbH
11.5.1 EXTEDO GmbH Company Detail
11.5.2 EXTEDO GmbH Business Overview
11.5.3 EXTEDO GmbH Drug Safety and Pharmacovigilance Software Introduction
11.5.4 EXTEDO GmbH Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.5.5 EXTEDO GmbH Recent Development
11.6 Online Business Applications Inc
11.6.1 Online Business Applications Inc Company Detail
11.6.2 Online Business Applications Inc Business Overview
11.6.3 Online Business Applications Inc Drug Safety and Pharmacovigilance Software Introduction
11.6.4 Online Business Applications Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.6.5 Online Business Applications Inc Recent Development
11.7 Oracle Corporation
11.7.1 Oracle Corporation Company Detail
11.7.2 Oracle Corporation Business Overview
11.7.3 Oracle Corporation Drug Safety and Pharmacovigilance Software Introduction
11.7.4 Oracle Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.7.5 Oracle Corporation Recent Development
11.8 Sparta Systems, Inc.
11.8.1 Sparta Systems, Inc. Company Detail
11.8.2 Sparta Systems, Inc. Business Overview
11.8.3 Sparta Systems, Inc. Drug Safety and Pharmacovigilance Software Introduction
11.8.4 Sparta Systems, Inc. Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.8.5 Sparta Systems, Inc. Recent Development
11.9 United BioSource Corporation
11.9.1 United BioSource Corporation Company Detail
11.9.2 United BioSource Corporation Business Overview
11.9.3 United BioSource Corporation Drug Safety and Pharmacovigilance Software Introduction
11.9.4 United BioSource Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.9.5 United BioSource Corporation Recent Development
11.10 Sarjen Systems
11.10.1 Sarjen Systems Company Detail
11.10.2 Sarjen Systems Business Overview
11.10.3 Sarjen Systems Drug Safety and Pharmacovigilance Software Introduction
11.10.4 Sarjen Systems Revenue in Drug Safety and Pharmacovigilance Software Business (2019-2024)
11.10.5 Sarjen Systems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
